{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:36:30Z","timestamp":1789184190593,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1245\/s10434-020-08610-7","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T17:06:12Z","timestamp":1591290372000},"page":"295-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?"],"prefix":"10.1245","volume":"28","author":[{"given":"Anita","family":"Mamtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Romanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Baser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"issue":"14","key":"8610_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/jama.2009.1450","volume":"302","author":"M Morrow","year":"2009","unstructured":"Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302(14):1551\u20136.","journal-title":"JAMA"},{"issue":"3","key":"8610_CR2","first-page":"193","volume":"11","author":"DR Faverly","year":"1994","unstructured":"Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;11(3):193\u20138.","journal-title":"Semin Diagn Pathol"},{"issue":"32","key":"8610_CR3","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F Warnberg","year":"2014","unstructured":"Warnberg F, Garmo H, Emdin S, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20\u00a0years follow-up in the randomized SweDCIS Trial. J Clin Oncol. 2014;32(32):3613\u20138.","journal-title":"J Clin Oncol"},{"issue":"32","key":"8610_CR4","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker M, Litiere S, Werutsky G, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol. 2013;31(32):4054\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"8610_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"41","key":"8610_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","volume":"2010","author":"C Correa","year":"2010","unstructured":"Correa C, McGale P, Taylor C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162\u201377.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"8610_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1245\/s10434-009-0765-1","volume":"17","author":"M Azu","year":"2010","unstructured":"Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol. 2010;17(2):558\u201363.","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"8610_CR8","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","volume":"34","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol. 2016;34(33):4040\u20136.","journal-title":"J Clin Oncol"},{"issue":"12","key":"8610_CR9","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","volume":"23","author":"ML Marinovich","year":"2016","unstructured":"Marinovich ML, Azizi L, Macaskill P, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2016;23(12):3811\u201321.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"8610_CR10","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1245\/s10434-016-5397-7","volume":"23","author":"LH Rosenberger","year":"2016","unstructured":"Rosenberger LH, Mamtani A, Fuzesi S, et al. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol. 2016;23(10):3239\u201346.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"8610_CR11","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1245\/s10434-015-4829-0","volume":"22","author":"A Chung","year":"2015","unstructured":"Chung A, Gangi A, Amersi F, Bose S, Zhang X, Giuliano A. Impact of consensus guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on margins for breast-conserving surgery in stages 1 and 2 invasive breast cancer. Ann Surg Oncol. 2015;22(Suppl 3):S422\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8610_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jamcollsurg.2018.01.050","volume":"227","author":"N Bhutiani","year":"2018","unstructured":"Bhutiani N, Mercer MK, Bachman KC, et al. Evaluating the effect of margin consensus guideline publication on operative patterns and financial impact of breast cancer operation. J Am Coll Surg. 2018;227(1):6\u201311.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"8610_CR13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1245\/s10434-019-07247-5","volume":"26","author":"L Havel","year":"2019","unstructured":"Havel L, Naik H, Ramirez L, Morrow M, Landercasper J. Impact of the SSO-ASTRO margin guideline on rates of re-excision after lumpectomy for breast cancer: a meta-analysis. Ann Surg Oncol. 2019;26(5):1238\u201344.","journal-title":"Ann Surg Oncol"},{"key":"8610_CR14","unstructured":"R Core Team (2019) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 3 Mar 2020."},{"issue":"10","key":"8610_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2017.0774","volume":"3","author":"M Morrow","year":"2017","unstructured":"Morrow M, Abrahamse P, Hofer TP, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3(10):1352\u20137.","journal-title":"JAMA Oncol"},{"issue":"10","key":"8610_CR16","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1245\/s10434-018-6580-9","volume":"25","author":"SM DeSnyder","year":"2018","unstructured":"DeSnyder SM, Hunt KK, Dong W, et al. American Society of Breast Surgeons\u2019 practice patterns after publication of the SSO-ASTRO-ASCO DCIS consensus guideline on margins for breast-conserving surgery with whole-breast irradiation. Ann Surg Oncol. 2018;25(10):2965\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"8610_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/SLA.0000000000002439","volume":"269","author":"AB Tadros","year":"2019","unstructured":"Tadros AB, Smith BD, Shen Y, et al. Ductal carcinoma in situ and margins\u2009<\u20092\u00a0mm: contemporary outcomes with breast conservation. Ann Surg. 2019;269(1):150\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"8610_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/jamasurg.2016.4751","volume":"152","author":"L Langhans","year":"2017","unstructured":"Langhans L, Jensen MB, Talman MM, Vejborg I, Kroman N, Tvedskov TF. Reoperation rates in ductal carcinoma in situ vs invasive breast cancer after wire-guided breast-conserving surgery. JAMA Surg. 2017;152(4):378\u201384.","journal-title":"JAMA Surg"},{"issue":"12","key":"8610_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/jamasurg.2014.926","volume":"149","author":"LG Wilke","year":"2014","unstructured":"Wilke LG, Czechura T, Wang C, et al. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004\u20132010. JAMA Surg. 2014;149(12):1296\u2013305.","journal-title":"JAMA Surg"},{"issue":"7","key":"8610_CR20","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1245\/s10434-014-4334-x","volume":"22","author":"CE Rutter","year":"2015","unstructured":"Rutter CE, Park HS, Killelea BK, Evans SB. Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States. Ann Surg Oncol. 2015;22(7):2378\u201386.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"8610_CR21","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.clbc.2017.08.001","volume":"18","author":"HL Park","year":"2018","unstructured":"Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in treatment patterns and clinical outcomes in young women diagnosed with ductal carcinoma in situ. Clin Breast Cancer. 2018;18(2):e179\u201385.","journal-title":"Clin Breast Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08610-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:09:57Z","timestamp":1622761797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08610-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["8610"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08610-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The preparation of this manuscript was supported in part by NIH\/NCI Cancer Center Support Grant No. P30 CA008748 to Memorial Sloan Kettering Cancer Center, and this study was accepted for presentation in ePoster format at the 2020 Society of Surgical Oncology International Conference on Surgical Cancer Care. Dr. Monica Morrow has received honoraria from Genomic Health, and all other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}